Biotech Leaders Urge President Trump and Congress to Preserve DACA




To:       President Donald J. Trump

CC:      Speaker Paul Ryan; Leader Nancy Pelosi; Leader Mitch McConnell; Leader Charles E.
             Schumer; Members of the Senate; and, Members of the House of Representatives

From:   Leaders in the Biotechnology Industry

Re:       Preserve the Deferred Action for Childhood Arrivals (DACA) Program

Dear President Trump:

We, the 185 signatories to this letter, are entrepreneurs and business leaders in the Biotechnology Industry. We are deeply concerned about new developments in immigration policy that threaten the future of young undocumented immigrants brought to America as children. We ask you to reconsider your decision to rescind the DACA program.

The DACA program, which allows nearly 800,000 Dreamers the basic opportunity to work and study without the threat of deportation, is in jeopardy. All DACA recipients grew up in America, registered with our government, submitted to extensive background checks, and are diligently giving back to our communities and paying income taxes. More than 97 percent are in school or in the workforce, 5 percent started their own business, 65 percent have purchased a vehicle, and 16 percent have purchased their first home. At least 72 percent of the top 25 Fortune 500 companies count DACA recipients among their employees.

Unless we act now to preserve the DACA program, all 780,000 hardworking young people will lose their ability to work legally in this country, and every one of them will be at risk of deportation. Our economy would lose $460.3 billion from the national GDP and $24.6 billion in Social Security and Medicare tax contributions.

We call on you, President Trump, to reverse your decision and preserve the DACA program. We call on Congress to pass the bipartisan DREAM Act or legislation that provides these young people raised in our country the permanent solution they deserve.

Dreamers are vital to the future of our companies in the Biotechnology Industry. With them, we grow and create jobs. Dreamers are part of why we will continue to have a global competitive advantage and the world’s leading Biotechnology Industry.

Respectfully, and on behalf of all signatories,
 
                                          Steven H. Holtzman                                  Jeremy M. Levin
                                          President & CEO                                      Chairman & CEO
                                          Decibel Therapeutics                                Ovid Therapeutics


Mark Levin, Partner Third Rock Ventures
John Maraganore, CEO Alnylam Pharmaceuticals
George Scangos, CEO Vir Bio
David Schenkein, CEO Agios
Bassil Dahiyat, President & CEO Xencor, Inc.
Paul Sekhri, President & CEO Lycera Corp.
Cedric Francois, President & CEO Apellis Pharmaceuticals
Paula K. Cobb, EVP Corporate Development Decibel Therapeutics
Bernat Olle, CEO Vedanta Biosciences
Robert Nelsen, Co-founder & Managing Director ARCH Venture Partners
Jeb Keiper, CFO & CBO Nimbus Therapeutics
Barry Greene, President Alnylam Pharmaceuticals
Pablo Cagnoni, President & CEO Tizona Therapeutics
Brook Byers, Partner Kleiner Perkins Caufield & Byers
Jean Francois Formela, Partner Atlas Venture
Alex Martin, CEO Realm Therapeutics
Jay Short, CEO BioAtla
David Baltimore, Board member of Biotech firms, Professor of Biology, Caltech and Nobel Laureate in Physiology or Medicine, 1975
Daniel Teper, CEO Cytovia Oncology
Stuart L. Schreiber, Co-Founder Broad Institute
Peter Kolchinsky, Managing Partner RA Capital Management, LLC
Yaron Werber, Chief Business & Financial Officer Ovid Therapeutics
Brian J. G. Pereira, CEO Visterra
Ron Cohen, President & CEO Acorda Therapeutics
Tony Coles, CEO Yumanity
Ted Love, CEO Global Blood Therapeutics
Joel Martin, President & CEO Dauntless Therapeutics
Sandy Zweifach, President & CEO Nuvelution Pharma
Stewart Parker, Principal Parker BioConsulting
Steven Gillis, Partner Arch Venture Partners
Ken Moch, President & CEO Cognition Therapeutics
Jason Rhodes, Partner Atlas Venture
Matthew Perry, President & CEO BVF Partners
Stephen Isaacs, Chairman, President & CEO Aduro Biotech, Inc.
Gerhard Koenig, President & CEO Quartet Medicine
John P. Butler, President & CEO Akebia Therapeutics
Ronald A. DePinho, Past President & Distinguished University Professor, The University of Texas MD Anderson Cancer Center
Rakesh K. Jain, Director E.L. Steele Laboratories, MGH
Nancy Simonian, CEO Syros Pharmaceuticals
Samuel D. Waksal, Founder Kadmon Corporation
William J. Newell, CEO Sutro Biopharma
Nancy A. Thornberry, CEO Kallyope
Amit Rakhit, Chief Medical & Portfolio Officer Ovid Therapeutics
Laurence Reid, CEO Warp Drive Bio
Michael D Clayman, CEO Flexion Therapeutics
William Slattery, Partner Deerfield Management
Bruce A. Leicher, Sr. VP & General Counsel Momenta Pharmaceuticals
Clifford J. Stocks, CEO OncoResponse
Jonathan J. Fleming, President & CEO Q-State Biosciences Corporation
John Osborn, Board Member Egalet Corporation
David S. Block, Chairman & CEO Gliknik Inc.
Perry Karsen, Chair of the Board Intellia Therapeutics
Clay Siegall, CEO Seattle Genetics
Paul Abrams, Chairman Nexgen Medical Systems
Rusty Williams, Chairman & CEO Five Prime Therapeutics
Thomas Shenk, Professor Princeton University
Michel Vounatsos, CEO Biogen
Arthur Tzianabos, President & CEO Homology Medicines
Maxine Gowen, President & CEO Trevena
Rajeev Shah, Managing Dir. & Portfolio Manager RA Capital Management
Chip Clark, CEO Genocea Biosciences
David V. Goeddel, Managing Partner The Column Group
Kleanthis Xanthopoulos, Managing Gen. Partner Cerus Advisors
Emil Kakkis, CEO & President Ultragenyx Pharmaceutical
Hugh O'Dowd, CEO Neon Therapeutics
Hans Bishop, CEO Juno Therapeutics
Alan Crane, Partner & Entrepreneur Polaris Partners
Douglas Doerfler, President & CEO MaxCyte
Camille Samuels, Partner Venrock
Tom Cirrito, CEO Filament BioSolutions
Mark A. Goldsmith, President & CEO REVOLUTION Medicines
Ronald C. Renaud, Jr, CEO Translate Bio
Julia Owens, President & CEO Millendo Therapeutics
Zoe Barry, Founder & CEO ZappRx
Uri Lopatin, CMO Assembly Biosciences
Gail J. Maderis, President & CEO Antiva Biosciences
David R. Liu, Professor Harvard University & Broad Institute
Mara G. Aspinall, CEO Health Catalysts
Patrick J Mahaffy, President & CEO Clovis Oncology
William J. Rieflin, CEO NGM BIO
Otello Stampacchia, Managing Director Omega Funds
Michael Bonney, Chair Alnylam Pharmaceuticals
Lillian Chiang, President & CEO FORGE Life Science
Jeffrey Brewer, President & CEO Bigfoot Biomedical
Jeff Jonker, President NGM Bio
Robert Kamen, Entrepreneur in Residence Third Rock Ventures
Jeff Stein, President & CEO Cidara Therapeutics
Harvey F. Lodish, Member Whitehead Institute for Biomedical Research
Ashley Dombkowski, CEO & Co-founder Before Brands
Paul Laikind, President & CEO ViaCyte
Ailis Tweed-Kent, Founder & CEO Cocoon Biotech
Brian M. Gallagher, Jr, Partner SR One Ltd.
Ryan J. Watts, President & CEO Denali Therapeutics
Paul Bolno, President & CEO Wave Life Sciences
Ankit Mahadevia, CEO Spero Therapeutics
Anna Forsythe, CEO Purple Squirrel Economics
Michael Morrissey, CEO Exelixis
Rob Perez, Founder & Chairman Life Science Cares
Daphne Zohar, Founder & CEO PureTech Health
Martin Tolar, Founder, President & CEO Alzheon
Laura Shawver, CEO Cleave Biosciences
Akshay Vaishnaw, EVP, R&D Alnylam Pharmaceuticals
Bill Rastetter, Chairman & CEO Grail
Rachel King, CEO Glycomimetics
Simba Gill, CEO Evelo Biosciences
Eric Dobmeier, COO Seattle Genetics
Robert I. Blum, President & CEO Cytokinetics
Martin Babler, CEO Principia Biopharma
Hugo Peris, President Spiral Therapeutics
Adam Gridley, President & CEO Histogenics Corporation
Gregory Went, CEO & Chairman Adamas Pharmaceuticals
Neil Kumar, CEO BridgeBio Pharma
Bob Coughlin, CEO MassBio
Paula Ness Spears, Managing Director Health Advances LLC
Mark Speers, Managing Director Health Advances LLC
Andrew Funderburk, Partner Health Advances LLC
Sheela Hegde, Partner Health Advances LLC
Donna Hochberg, Partner Health Advances LLC
Wyatt Gotbetter, Partner Health Advances LLC
Gary Gustavsen, Partner Health Advances LLC
Andrew Matzkin, Partner Health Advances LLC
Vivek Mittal, Partner Health Advances LLC
Susan Posner, Partner Health Advances LLC
Peter Strumph, President & CEO Amygdala Neurosciences
Jeff Behrens, President & CEO Siamab Therapeutics
Michael Gilman, Chairman & CEO Arrakis Therapeutics
Atul Pande, CMO PureTech Health
Robert Forrester, President & CEO Verastem
Marco Taglietti, President & CEO SCYNEXIS
Sean George, CEO Invitae
Andy Palmer, CIO (retired) Infinity Pharmaceuticals
George P. Vlasuk, President & CEO Navitor Pharmaceuticals
Larry Green, Founder & CEO Ablexis
Kia Motesharei, VP & Global Head of BD, N&I Merck KGaA
Mark A. Murcko, CSO Relay Therapeutics
Jeffrey L. Cleland, President & CEO Graybug Vision
Gonul Velicelebi, Founder & CEO Camino Pharma
Melyssa Weible, Managing Partner & Co-Founder Elixir Health PR
Alan Levy, CEO Chrono Therapeutics
Ram Sasisekharan, Professor & Entrepreneur Koch Institute & MIT
Nagesh K. Mahanthappa, President & CEO Scholar Rock
Nima Farzan, CEO PaxVax
Cary G. Pfeffer, Partner Third Rock Ventures
Bob More, General Partner Alta Partners
Mike Powell, General Partner Sofinnova Ventures
Shin-San Michael Su, CSO Decibel Therapeutics
Constance McKee, President & CEO Manzanita Pharmaceuticals
Lynn Hanessian, Chief Strategist Edelman
Sunil Joshi, Managing Director Strategi.us Consulting
Justin Klein, Partner New Enterprise Associates
Laurent Fischer, Former CEO Tobira Therapeutics
Jeffrey Kaplan, Partner Deerfield Management
John Lee, SVP, Pharmaceutical Development Decibel Therapeutics
Nick Galakatos, Co-Founder & Managing Director Clarus Funds
Heather Franklin, President & CEO Blaze Bioscience
Jonathon Leff, Partner Deerfield Management
Jeffrey Jacob, CEO Cancer Prevention Pharmaceuticals
Faheem Hasnain, Chairman Tocagen
Renee Russo, President & CEO Arsanis
H. Robert Horvitz, David H. Koch Professor of Biology, MIT and Nobel Laureate in Physiology or Medicine, 2002
Wendell Wierenga, Chairman Crinetics Pharmaceuticals
Eddie Martucci, Co-Founder & CEO Akili
Neil Exter, Partner Third Rock Ventures
Tim Harris, EVP R&D Bioverativ
Jim Geraghty, Chairman Juniper Pharmaceuticals
Christian V. Kuhlen, General Counsel Ignyta
Hervé Hoppenot, Chairman & CEO Incyte
Tuan Ha-Ngoc, Executive Chairman KEW
Gregory J. Flesher, President & CEO Novus Therapeutics
Julian Adams, CEO Aldila Therapeutics
Deborah Dunsire, CEO XTuit Pharmaceuticals
Vanessa King, Biotech Entrepreneur Atlas Advisor
Douglas E. Williams, President & CEO Codiak BioSciences
Brian M. Cali, Founder & SVP, R&D Strategy and External Innovation Ironwood Pharmaceuticals
Nick Leschly, Chief Bluebird bluebird bio
Scott Koenig, President & CEO MacroGenics
Richard Heyman, Executive Chair Metacrine
Robert Tepper, Partner Third Rock Ventures
Guy Macdonald, CEO Tetraphase
Stephen Sherwin, Clinical Professor of Medicine UCSF
Tanya Shnaydman, Corporate Communications Santen Pharmaceutical
Cigall Kadoch, Scientific Founder Foghorn Therapeutics
Bill Haney, CEO Dragonfly Therapeutics

Comments

  1. Bruce DavidFebruary 7, 2019 at 6:49 AM

    Hello everyone..Welcome to my free masterclass strategy where i teach experience and inexperience traders the secret behind a successful trade.And how to be profitable in trading I will also teach you how to make a profit of $12,000 USD weekly and how to get back all your lost funds feel free to email me on(brucedavid004@gmail.com) or whataspp number is



    Hello everyone..Welcome to my free masterclass strategy where i teach experience and inexperience traders the secret behind a successful trade.And how to be profitable in trading I will also teach you how to make a profit of $12,000 USD weekly and how to get back all your lost funds feel free to email me on(brucedavid004@gmail.com) or whataspp number is

    ReplyDelete
    Replies
    1. AnonymousApril 27, 2022 at 7:40 AM

      Biotech Leaders Urge President Trump And Congress To Preserve Daca >>>>> Download Now

      >>>>> Download Full

      Biotech Leaders Urge President Trump And Congress To Preserve Daca >>>>> Download LINK

      >>>>> Download Now

      Biotech Leaders Urge President Trump And Congress To Preserve Daca >>>>> Download Full

      >>>>> Download LINK IN

      Delete
  2. AlvirMay 6, 2020 at 7:21 PM

    I never thought I will come in contact with a real and potential hacker until I knew   brillianthackers800 at Gmail and he delivered a professional job,he is intelligent and understanding to control jobs that comes his way
    Contact him and be happy

    ReplyDelete
  3. ElizabethMay 14, 2020 at 10:10 AM

    An hacker helped me to spy on my wife’s WhatsApp,mails and every text message that was sent to her iPhone and every deleted messages of the past six months you can message him through this number (+13852501115) or contact him via email at brillianthackers800@gmail.com

    ReplyDelete
  4. Kavita PheerangeeMay 24, 2020 at 4:18 PM


    Hi everyone, I saw comments from people who had already got Blank ATM Cards from Mike Fisher. Honestly I thought it was a scam, and then I decided to make a request based on their recommendations. A few days ago, I confirmed in my door step to have received my blank card to withdraw 12,000 euros, which I requested for business. This is really good news and I am so happy that I advise all those who need a real HACKER should contact him and who are sure to reimburse to apply through their email (text or call) +1 315-329-6320 There are sincere Hackers
    They are able to Delivered your Blank ATM Cards
    Contact Mr Mike
    E-mail: blankatm002@gmail.com
    Telephone: +1(301) 329-5298

    ReplyDelete
  5. Andrea RobertsonAugust 25, 2020 at 7:46 AM

    He is no scam,i tested him and he delivered a good job,he helped me settle bank loans,he also helped my son upgrade his scores at high school final year which made him graduate successfully and he gave my son free scholarship into the college,all i had to do was to settle the bills for the tools on the job,i used $500 to get a job of over $50000 done all thanks to Walt,he saved me from all my troubles,sharing this is how i can show gratitude in return for all he has done for me and my family

    Gmail; Brillianthackers800@gmail.com
    Whatsapp number; +1(224)2140835

    ReplyDelete
  6. Robbie Payton 952@gmail.comNovember 11, 2021 at 2:48 PM

    Hello
    We are professional traders, earning on forex and binary for investors weekly, will love to tell you all more about our investment platform where you can invest funds as little as $500 and start earning $5,500 weekly, alot of people has benefited from this investment offer before and during this convid-19 virus, if you passing through financial difficulties due to this coronavirus and you need help paying bills simply choose a suitable investment plan for yourself and start making profit weekly $500 to earn $5,000 in 7 days
    $1000 to earn $10000 in 7 days
    $5000 to earn $50000 in 7 days To Start your investment now contact Via whatsapp: +1 (512) 975 2877 or email ✉️contact@koinbuzzcompany.com

    ReplyDelete
  7. JacobMarch 26, 2022 at 10:11 PM

    LEGIT FULLZ & TOOLS STORE

    Hello to All !

    We are offering all types of tools & Fullz on discounted price.
    If you are in search of anything regarding fullz, tools, tutorials, Hack Pack, etc
    Feel Free to contact

    ***CONTACT 24/7***
    **Telegram > @leadsupplier
    **ICQ > 752822040
    **Skype > Peeterhacks
    **Wicker me > peeterhacks

    "SSN LEADS/FULLZ AVAILABLE"
    "TOOLS & TUTORIALS AVAILABLE FOR HACKING, SPAMMING,
    CARDING, CASHOUT, CLONING, SCRIPTING ETC"

    **************************************
    "Fresh Spammed SSN Fullz info included"
    >>SSN FULLZ with complete info
    >>CC With CVV Fullz USA
    >>FULLZ FOR SBA, PUA & TAX RETURN FILLING
    >>USA I.D Photos Front & Back
    >>High Credit Score fullz (700+ Scores)
    >>DL number, Employee Details, Bank Details Included
    >>Complete Premium Info with Relative Info

    ***************************************
    COMPLETE GUIDE FOR TUTORIALS & TOOLS

    "SPAMMING" "HACKING" "CARDING" "CASH OUT"
    "KALI LINUX" "BLOCKCHAIN BLUE PRINTS" "SCRIPTING"
    "FRAUD BIBLE"

    "TOOLS & TUTORIALS LIST"
    =>Ethical Hacking Ebooks, Tools & Tutorials
    =>Bitcoin Hacking
    =>Kali Linux
    =>Fraud Bible
    =>RAT
    =>Keylogger & Keystroke Logger
    =>Whatsapp Hacking & Hacked Version of Whatsapp
    =>Facebook & Google Hacking
    =>Bitcoin Flasher
    =>SQL Injector
    =>Premium Logs (PayPal/Amazon/Coinbase/Netflix/FedEx/Banks)
    =>Bitcoin Cracker
    =>SMTP Linux Root
    =>Shell Scripting
    =>DUMPS with pins track 1 and 2 with & without pin
    =>SMTP's, Safe Socks, Rdp's brute
    =>PHP mailer
    =>SMS Sender & Email Blaster
    =>Cpanel
    =>Server I.P's & Proxies
    =>Viruses & VPN's
    =>HQ Email Combo (Gmail, Yahoo, Hotmail, MSN, AOL, etc.)

    *Serious buyers will always welcome
    *Price will be reduce in bulk order
    *Discount offers will gives to serious buyers
    *Hope we do a great business together

    ===>Contact 24/7<===
    ==>Telegram > @leadsupplier
    ==>ICQ > 752822040
    ==>Skype > Peeterhacks
    ==>Wicker me > peeterhacks

    ReplyDelete
  8. AnonymousApril 27, 2022 at 7:39 AM

    Biotech Leaders Urge President Trump And Congress To Preserve Daca >>>>> Download Now

    >>>>> Download Full

    Biotech Leaders Urge President Trump And Congress To Preserve Daca >>>>> Download LINK

    >>>>> Download Now

    Biotech Leaders Urge President Trump And Congress To Preserve Daca >>>>> Download Full

    >>>>> Download LINK VQ

    ReplyDelete

Post a Comment

Popular posts from this blog

Early-Stage Biotech Value Creation: The Roles of Equity and Partnerships

Image
WARNING TO THE READER : this piece is REALLY LONG . Its genesis lay in my current efforts to develop a business/financing strategy for Decibel Therapeutics.   In that context, I have been giving thought to how others have been successful—and failed—in such endeavors.   The piece starts with my thoughts. It is then followed by responses to these thoughts by three great thinkers (and friends) in the biotech industry: Mark Levin, John Maraganore, and Jeff Tong, who reviewed an earlier draft. My replies to their responses are also included. In fact, there are two rounds of responses and replies. The publication of this piece on a blog, which has a “comment” functionality, is intended to enable additional colleagues in the industry (including you) to join the conversation if they/you so desire. Invariably I find that responses to my thoughts are much more insightful than anything I have to say. In addition to being very long, the piece features extensive endnotes . I tried to
Read more

Biotech Leaders Call for a Free Press

Re cently, John Maraganore, Ron Cohen, Jeremy Levin, and I wrote a letter strongly objecting to the President's unremitting attacks on the Press.   We believe that freedom of speech, as embodied in a free press, is essential to the free exchange of ideas that is at the foundation of scientific discourse and, hence, biotechnology (not to mention a functional democracy).  Life science has an unfortunate history of being undermined by ideology.  It is critical for those of us who have assumed the responsibility for transforming that science into safe and effective new medicines to stand firm against any effort that would undermine the basis of scientific discourse.  That is a path down a rabbit hole to a land in which facts are met with equal validity by alternative facts and the truth becomes the dictate of the politically and economically powerful. The letter we wrote was circulated among our colleagues in the industry.  Over 150 biotech leaders joined us as signatories. 
Read more

BIO and Topless Dancers: Where to Cast Our Ayes

BIO and Topless Dancers: Where to Cast Our Ayes NOTE : the main body of this piece was written in July 2018 immediately following the incidents described herein that took place in conjunction with the 2018 BIO Annual Meeting.   The Epilogue has just been added (October 6, 2018). =========================================== The event of topless dancers at a party held in conjunction with the recent BIO conference has occasioned quite a tizzy in the biotech twitter-sphere.   Recapping the narrative trope: A party features topless women dancers bearing the painted logos of companies that sponsored the event.   Photos of the women circulate John Maraganore, CEO of Alnylam and, importantly in this context, current Chair of BIO, tweets and is interviewed saying that sponsorship of such behavior is unacceptable and inconsistent with the values of the biotechnology industry o    Given Maraganore’s role as Chair of BIO, this carries an implication that companies sponsorin
Read more